Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 401 - 420 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »
Reset 

Akesis Previews Next-Generation Galaxy SRS and New LINAC Platform at ASTRO

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2019

New Interim Data in RRMM Patients With Extramedullary Disease from the Pivotal Phase 2 Horizon-study Presented at International Myeloma Workshop

STOCKHOLM, Sept. 15, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today updated interim efficacy and safety data from the ongoing pivotal Phase 2 study, HORIZON, at the 17th International Myeloma Workshop (IMW) meeting in Boston, Massachusetts, USA. The... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2019
Related companies:  Oncopeptides AB

Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting

PALO ALTO, Calif., Sept. 15, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced emerging durability data in patients with wet age-related macular... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2019
Related companies:  Kodiak Sciences Inc.

New DARZALEX® (daratumumab) Data from GRIFFIN Study Show High Response Rate and Depth of Response in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant-Eligible

BOSTON, Sept. 15, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized Phase 2 GRIFFIN (Read more ››

By: PR Newswire Association LLC. - 15 Sep 2019
Related companies:  Johnson & Johnson

TAE Life Sciences Announces Scientific Advisory Board to Advance Cancer Research in Boron-Neutron Capture Therapy

FOOTHILL RANCH, Calif., Sept. 15, 2019 /PRNewswire/ -- TAE Life Sciences, a company pioneering a new cancer treatment... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2019
Related companies:  TAE Life Sciences

Five US patents granted for non-invasively treating migraine headaches in the most unexpected of ways - gentle air pressure changes in the ear

TEMPE, Ariz., Sept. 15, 2019 /PRNewswire/ -- Nocira, LLC announces its fourth and fifth US Patents, US 10,251,790 and 10,278,868, issued by the U.S. Patent and Trademark Office related to its novel approach for treating headaches via ear pressure modulation.

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2019

Varian Unveils Innovative New Solution for Adaptive Therapy

PALO ALTO, Calif., Sept. 15, 2019 /PRNewswire/ -- Strengthening its leadership in delivering innovative new solutions to transform cancer care globally, Varian (NYSE: VAR) today announced Ethos((TM)) therapy, an Adaptive Intelligence((TM)) solution. Ethos therapy is an artificial intelligence... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2019
Related companies:  Varian Medical Systems, Inc.

Radius Health to Present Data on Abaloparatide at ASBMR 2019 Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2019
Related companies:  Radius Health, Inc.

BioRestorative Therapies Comments on Recent Promotional Activity

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2019
Related companies:  BioRestorative Therapies, Inc.

Early detection is key: Screening test could improve lives of cats with heart disease

DENVER, Sept. 13, 2019 /PRNewswire/ -- A new, two-minute screening technique could help save cats from dying prematurely of heart disease. Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019

The Farm Management Tackles Social Responsibility for Businesses in Global Wellness Summit

NEW DELHI, Sept. 13, 2019 /PRNewswire/ -- Binod Chaudhary, Chairman of CG Corp Global, and other notable speakers and presenters from different corporations will be sharing their expert opinions about business and the wellness industry in Asia during the annual Global Wellness Summit to be held... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019

Kazia wins ANZLF Trans-Tasman Innovation & Growth Award and reports new data from clinical trial in childhood brain cancer

SYDNEY, Sept. 13, 2019 /PRNewswire/ -- Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) is pleased to announce that it has been named as a winner in the 2019 ANZLF Trans-Tasman Innovation & Growth Awards.

Read more ››
By: PR Newswire Association LLC. - 13 Sep 2019

MBP Solutions Marks 20 Years of Continued Business Growth with the Launch of an "Evolved", New Corporate Identity

NEUCHATEL, Switzerland, Sept. 13, 2019 /PRNewswire/ -- MBP Solutions, the pioneering and world-leading provider of biological by-product outsourcing services (OMBP), today celebrates its 20(th) anniversary in business and revealed its new, updated corporate identity - developed to support... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019

Mallinckrodt Analysis Suggests Acthar® Gel (Repository Corticotropin Injection) May be a Cost-Effective Option Compared to Other Late-Line, Adult Treatments for Multiple Sclerosis Relapse

STAINES-UPON-THAMES, United Kingdom, Sept. 13, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company,... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019
Related companies:  Mallinckrodt Plc

Largest Ever Hip Fracture Fixation Trial in Over 1,000 Patients Demonstrates Unprecedently Low Cut-Out Rates for X-BOLT® Device

DUBLIN, Sept. 13, 2019 /PRNewswire/ -- X-BOLT Orthopaedics, a leading medical device company, today announced preliminary results from the largest ever multi-centre randomised controlled trial comparing extracapsular hip fracture fixation devices, known as World Hip Trauma Evaluation 4 (WHITE4).... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019

Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference

SEATTLE and VANCOUVER, British Columbia, Sept. 13, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that two presentations... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019
Related companies:  Achieve Life Sciences,Inc.

Doctors and Med Students Announce Nationwide Stand on September 16 to End America's Firearms Epidemic

STANFORD, Calif., Sept. 13, 2019 /PRNewswire/ -- On Monday, September 16 at Stanford Medical Center and leading centers of medicine across the U.S., doctors, nurses, medical students, EMTs, and other healthcare professionals and supporters will stand together for the second year to accept the... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019

HHS Office of Inspector General Report Shows Rebates Reduced Medicare Part D Drug Spending

WASHINGTON, Sept. 13, 2019 /PRNewswire/ -- Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Health and Human Services Officer of Inspector General Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019
Related companies:  Johnson & Johnson | Biotechnology Health Management and Care, LLC

Golden Leaf Holdings Ltd. Announces New Interim CFO

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019

Medtronic Named a Leading Sustainability Company

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  Medtronic Plc
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »
to the top ↑